Investors & Media

Ionis to present at upcoming investor conference

CARLSBAD, Calif. , July 5, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a fireside chat at TD Cowen’s 2nd Annual RNA Therapeutics Summit on Monday, July 10, 2023 .     A live webcast of this presentation can be accessed on the

Read more
You are now leaving to visit